Davenport & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,577
| Closed | -$237K | – | 1187 |
|
|
2025
Q1 | $237K | Sell |
1,577
-14,469
| -90% | -$2.18M | ﹤0.01% | 1057 |
|
|
2024
Q4 | $2.94M | Sell |
16,046
-701
| -4% | -$129K | 0.02% | 389 |
|
|
2024
Q3 | $3.32M | Sell |
16,747
-1,742
| -9% | -$345K | 0.02% | 356 |
|
|
2024
Q2 | $3.83M | Buy |
18,489
+5,582
| +43% | +$1.16M | 0.02% | 327 |
|
|
2024
Q1 | $3.48M | Buy |
12,907
+4,925
| +62% | +$1.33M | 0.02% | 345 |
|
|
2023
Q4 | $1.9M | Buy |
+7,982
| New | +$1.9M | 0.01% | 415 |
|
|
2022
Q3 | – | Sell |
-939
| Closed | -$201K | – | 979 |
|
|
2022
Q2 | $201K | Buy |
939
+85
| +10% | +$18.2K | ﹤0.01% | 897 |
|
|
2022
Q1 | $243K | Sell |
854
-112
| -12% | -$31.9K | ﹤0.01% | 924 |
|
|
2021
Q4 | $364K | Sell |
966
-530
| -35% | -$200K | ﹤0.01% | 822 |
|
|
2021
Q3 | $617K | Buy |
1,496
+793
| +113% | +$327K | ﹤0.01% | 669 |
|
|
2021
Q2 | $260K | Buy |
+703
| New | +$260K | ﹤0.01% | 839 |
|